KDT Advisors’s Amgen AMGN Stock Holding History

KDT Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$229K	Hold	650	–	–	0.36%	68
2025 Q4	$213K	Buy	+650	New	+$206K	0.3%	70
2025 Q2	–	Sell	-650	Closed	-$203K	–	71
2025 Q1	$203K	Buy	+650	New	+$192K	0.3%	72

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

KDT Advisors's AMGN Position: Q1 2026 in Review

KDT Advisors held its Amgen (AMGN) position steady in Q1 2026 at 650 shares worth $229K. The position accounts for 0.36% of the portfolio, ranked #68.

KDT Advisors first reported a position in AMGN in Q1 2025 and has held it in 3 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

KDT Advisors held 650 shares of Amgen worth $229K as of Q1 2026.
KDT Advisors left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.36% of KDT Advisors's portfolio in Q1 2026, its #68 holding.
KDT Advisors first reported a position in Amgen in Q1 2025 and has held it in 3 quarters since.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on KDT Advisors's 13F filing for Q1 2026, filed 15 May 2026.